DFCM
IOVA icon

Dark Forest Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Dark Forest Capital Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,806
Closed -$32.3K – 1315
2025
Q2 		$32.3K Buy
18,806
+5,161
+38% +$12.8K ﹤0.01% 1140
2025
Q1 		$45.4K Sell
13,645
-3,257
-19% -$16.8K ﹤0.01% 1187
2024
Q4 		$125K Sell
16,902
-7,859
-32% -$72.8K 0.02% 844
2024
Q3 		$233K Sell
24,761
-20,097
-45% -$190K 0.03% 800
2024
Q2 		$360K Buy
+44,858
New +$481K 0.07% 387
2024
Q1 		– Sell
-11,703
Closed -$95.1K – 730
2023
Q4 		$95.1K Sell
11,703
-10,089
-46% -$52.8K 0.01% 410
2023
Q3 		$99.2K Sell
21,792
-14,589
-40% -$95.3K 0.01% 1051
2023
Q2 		$256K Buy
36,381
+33,742
+1,279% +$242K 0.02% 868
2023
Q1 		$16.1K Buy
2,639
+1,834
+228% +$12.7K ﹤0.01% 988
2022
Q4 		$5.14K Buy
+805
New +$6.29K ﹤0.01% 859
2022
Q3 		– Sell
-40
Closed – – 1270
2022
Q2 		$0 Buy
+40
New +$524 ﹤0.01% 1116
2022
Q1 		– Sell
-296
Closed -$6K – 1518
2021
Q4 		$6K Buy
+296
New +$6.52K ﹤0.01% 1097

Other funds holding IOVA

MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dark Forest Capital Management's IOVA Position: Q3 2025 in Review

Dark Forest Capital Management sold out of Iovance Biotherapeutics (IOVA) in Q3 2025, closing a stake of 18,806 shares — an estimated $32.3K sold.

Dark Forest Capital Management first reported a position in IOVA in Q4 2021 and held it in 12 quarters. The position peaked at $360K in Q2 2024. 253 funds tracked by Wall St. Rank hold IOVA as of Q3 2025.

  • Dark Forest Capital Management reported no remaining Iovance Biotherapeutics position as of Q3 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 18,806 Iovance Biotherapeutics shares in Q3 2025, an estimated $32.3K.
  • Dark Forest Capital Management first reported a position in Iovance Biotherapeutics in Q4 2021 and held it in 12 quarters.
  • Dark Forest Capital Management's Iovance Biotherapeutics position peaked at $360K in Q2 2024.
  • 253 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2025.

Based on Dark Forest Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.